AP NEWS
Related topics

Xenon Pharmaceuticals: 3Q Earnings Snapshot

November 5, 2019

BURNABY, British Columbia (AP) _ Xenon Pharmaceuticals Inc. (XENE) on Tuesday reported a loss of $8.9 million in its third quarter.

On a per-share basis, the Burnaby, British Columbia-based company said it had a loss of 33 cents.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 49 cents per share.

The gene therapy biotech company posted revenue of $3.5 million in the period.

Xenon Pharmaceuticals shares have climbed 45% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $9.15, a fall of 12% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XENE at https://www.zacks.com/ap/XENE